🇺🇸 FDA
Patent

US 10028961

Therapeutically active compounds and their methods of use

granted A61KA61K31/506A61K31/53

Quick answer

US patent 10028961 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/506, A61K31/53, A61K31/5377, A61K45/06